High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual

Takashi Kubo1, Yoshiki Matsuo, Yasushi Hayashi

  • 1Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.

Coronary Artery Disease
|October 27, 2009
PubMed

Insights

Elevated high-sensitivity C-reactive protein (hs-CRP) indicates more necrotic core in coronary plaques of stable angina patients. This suggests hs-CRP reflects ongoing plaque inflammation even in stable disease.

Area of Science:

  • Cardiology
  • Biomarkers
  • Vascular Biology

Background:

  • Elevated high-sensitivity C-reactive protein (hs-CRP) is linked to adverse outcomes in coronary artery disease.
  • Understanding the relationship between hs-CRP and coronary plaque characteristics is crucial for managing stable angina.

Purpose of the Study:

  • To investigate the association between serum hs-CRP levels and coronary plaque composition in patients with stable angina pectoris.
  • To determine if hs-CRP can serve as a marker for specific plaque morphologies.

Main Methods:

  • Virtual histology intravascular ultrasound (VH-IVUS) was used to analyze plaque composition.
  • 113 patients with stable angina and a culprit lesion were divided into elevated (>3 mg/l) and normal hs-CRP groups.
  • Correlations between hs-CRP levels and plaque components (necrotic core, calcium, fibrous tissue) were assessed.

Main Results:

  • Patients with elevated hs-CRP had significantly longer culprit lesions.
  • A greater percentage of necrotic core was observed in the elevated hs-CRP group compared to the normal hs-CRP group (20% vs. 16%, P=0.014).
  • Serum hs-CRP levels showed a positive correlation with the percentage of necrotic core (r=0.20, P=0.037).

Conclusions:

  • Elevated hs-CRP is associated with a higher proportion of necrotic core within culprit lesions in stable angina patients.
  • These findings suggest that hs-CRP may indicate inflammatory activity within coronary atherosclerotic plaques, even in stable disease states.
  • hs-CRP could be a valuable biomarker for assessing plaque vulnerability in stable coronary artery disease.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...